Potomac Capital Management, Inc. Adma Biologics, Inc. Transaction History

Potomac Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $894,140 - $1.4 Million	-362,000 Reduced 75.1%	120,000 $466,000
Q3 2022 Nov 14, 2022	SELL	$2.03 - $2.86 $96,018 - $135,278	-47,300 Reduced 8.94%	482,000 $1.17 Million
Q2 2022 Aug 03, 2022	SELL	$1.43 - $2.2 $351,351 - $540,540	-245,700 Reduced 31.7%	529,300 $1.05 Million
Q4 2021 Feb 07, 2022	BUY	$1.09 - $1.66 $844,750 - $1.29 Million	775,000 New	775,000 $1.09 Million

319

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.91B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Potomac Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Potomac Capital Management, Inc. with notifications on news.